CO6382136A2 - GLUCAGON ANALOGS - Google Patents

GLUCAGON ANALOGS

Info

Publication number
CO6382136A2
CO6382136A2 CO11074017A CO11074017A CO6382136A2 CO 6382136 A2 CO6382136 A2 CO 6382136A2 CO 11074017 A CO11074017 A CO 11074017A CO 11074017 A CO11074017 A CO 11074017A CO 6382136 A2 CO6382136 A2 CO 6382136A2
Authority
CO
Colombia
Prior art keywords
methods
glucagon analogs
peptides
glucagon
glp
Prior art date
Application number
CO11074017A
Other languages
Spanish (es)
Inventor
Eddi Meier
Ditte Riber
Marie Skovgaard
Bjarne Due Larsen
Jens Rosengren Daugaard
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Priority to CO11074017A priority Critical patent/CO6382136A2/en
Publication of CO6382136A2 publication Critical patent/CO6382136A2/en

Links

Abstract

La invención proporciona materiales y procedimientos para promover la pérdida de peso o prevenir el aumento de peso y en el tratamiento de diabetes, síndrome metabólico y trastornos asociados. En particular, la invención proporciona nuevos péptidos análogos de glucagón eficaces en tales procedimientos. Los péptidos pueden mediar su efecto teniendo selectividad aumentada para el receptor de GLP-1 en comparación con el glucagón humano.The invention provides materials and methods for promoting weight loss or preventing weight gain and in the treatment of diabetes, metabolic syndrome and associated disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. Peptides can mediate their effect by having increased selectivity for the GLP-1 receptor compared to human glucagon.

CO11074017A 2011-06-14 2011-06-14 GLUCAGON ANALOGS CO6382136A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO11074017A CO6382136A2 (en) 2011-06-14 2011-06-14 GLUCAGON ANALOGS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO11074017A CO6382136A2 (en) 2011-06-14 2011-06-14 GLUCAGON ANALOGS

Publications (1)

Publication Number Publication Date
CO6382136A2 true CO6382136A2 (en) 2012-02-15

Family

ID=45813937

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11074017A CO6382136A2 (en) 2011-06-14 2011-06-14 GLUCAGON ANALOGS

Country Status (1)

Country Link
CO (1) CO6382136A2 (en)

Similar Documents

Publication Publication Date Title
ECSP12011593A (en) GLUCAGON ANALOGS ACCILATED
UY35030A (en) GLUCAGON ANALOGS
UY33462A (en) GLUCAGON ANALOGS
ECSP12012357A (en) GLUCAGON ANALOGS
PH12016500675A1 (en) Acylated glucagon analogues
MX368435B (en) Glucagon analogues.
CL2014003421A1 (en) Glucagon analogs exhibiting agonist activity at the glusose-dependent insulinotropic peptide receptor (gip): pharmaceutical composition; and method to reduce weight gain or induce weight loss, particularly for the treatment of obesity.
MX2017012864A (en) Acylated glucagon analogue.
MX2011006315A (en) Glucagon analogues.
TN2011000295A1 (en) Glucagon analogues
MX2011006320A (en) Glucagon analogues.
MX2011006314A (en) Glucagon analogues.
UY34859A (en) Peptide analogs of exendin 4.
EA201490982A1 (en) ANALOGUE GLUACAGONA
CO6382136A2 (en) GLUCAGON ANALOGS
ECSP15009978A (en) GLUCAGON ANALOGUES
TN2011000667A1 (en) Acylated glucagon analogues